4142 — Adimmune Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSucker Stock

Annual cashflow statement for Adimmune, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-315	1,197	14.3	156	-770
Depreciation
Amortisation
Non-Cash Items	66.7	16.9	30.6	27.7	422
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-254	880	-751	-735	-769
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-262	2,322	-481	-292	-892
Capital Expenditures	-251	-553	-845	-341	-221
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-377	936	116	19.2	-145
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-627	383	-729	-322	-367
Financing Cash Flow Items	0	166	-212	279	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1,315	324	-223	823	859
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	427	3,034	-1,435	205	-400